Filing metadata

Accession number
0001127602-22-012095
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Apr 18, 2022
Reporting period
Apr 14, 2022
Description
Insider transaction

Explore SEC Filings Hub